You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PROAIR RESPICLICK Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Proair Respiclick patents expire, and when can generic versions of Proair Respiclick launch?

Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine patents protecting this drug.

This drug has two hundred and seven patent family members in twenty-seven countries.

The generic ingredient in PROAIR RESPICLICK is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proair Respiclick

A generic version of PROAIR RESPICLICK was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROAIR RESPICLICK?
  • What are the global sales for PROAIR RESPICLICK?
  • What is Average Wholesale Price for PROAIR RESPICLICK?
Drug patent expirations by year for PROAIR RESPICLICK
Drug Prices for PROAIR RESPICLICK

See drug prices for PROAIR RESPICLICK

Pharmacology for PROAIR RESPICLICK

US Patents and Regulatory Information for PROAIR RESPICLICK

PROAIR RESPICLICK is protected by nine US patents.

Patents protecting PROAIR RESPICLICK

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dry powder inhalation apparatus
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dry powder inhalation apparatus
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dry powder inhalation apparatus
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having a bore and shaft arrangement
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROAIR RESPICLICK

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PROAIR RESPICLICK

See the table below for patents covering PROAIR RESPICLICK around the world.

Country Patent Number Title Estimated Expiration
South Korea 101628934 ⤷  Sign Up
Austria 281861 ⤷  Sign Up
South Korea 20130103825 DOSE COUNTERS FOR INHALERS, INHALERS AND SHAFTS THEREOF ⤷  Sign Up
Poland 2514465 ⤷  Sign Up
South Korea 101618932 ⤷  Sign Up
United Kingdom 0115519 ⤷  Sign Up
San Marino T201500025 Contatori di dosi per inalatori e inalatori ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.